Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
XERS | US
0.07
2.41%
Healthcare
Biotechnology
30/06/2024
04/10/2024
2.98
3.03
3.04
2.98
Xeris Biopharma Holdings Inc. a biopharmaceutical company engages in developing and commercializing therapies in Illinois. The company markets Gvoke a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis a therapy for the treatment of hyperkalemic hypokalemic and related variants of primary periodic paralysis; and Recorlev a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago Illinois.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
45.0%1 month
44.2%3 months
57.6%6 months
56.5%-
-
3.34
-13.99
0.81
-3.36
3.42
-
-25.00M
444.02M
444.02M
-
-17.03
-
26.50
-617.16
6.34
7.56
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.35
Range1M
0.56
Range3M
0.99
Rel. volume
0.80
Price X volume
4.07M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
PureTech Health plc | PRTC | Biotechnology | 20.33 | 486.74M | 5.39% | n/a | 29.73% |
REGENXBIO Inc | RGNX | Biotechnology | 9.72 | 480.39M | -2.02% | n/a | 45.57% |
Anavex Life Sciences Corp | AVXL | Biotechnology | 5.595 | 474.43M | -1.06% | n/a | 0.00% |
OABI | OABI | Biotechnology | 3.99 | 471.47M | -1.97% | n/a | 8.27% |
Valneva SE | VALN | Biotechnology | 5.8116 | 471.18M | 1.78% | n/a | 126.08% |
Ginkgo Bioworks Holdings Inc. | DNA | Biotechnology | 8.33 | 462.94M | 8.04% | n/a | 54.29% |
EyePoint Pharmaceuticals Inc | EYPT | Biotechnology | 8.63 | 461.86M | 5.12% | n/a | 10.20% |
Quanterix Corporation | QTRX | Biotechnology | 11.9 | 456.71M | -4.80% | n/a | 11.75% |
Mind Medicine (MindMed) Inc. Subordinate Voting Shares | MNMD | Biotechnology | 5.57 | 456.67M | 0.36% | n/a | 12.00% |
Alector Inc | ALEC | Biotechnology | 4.62 | 449.62M | 2.67% | n/a | 23.98% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.36 | 0.76 | Cheaper |
Ent. to Revenue | 3.42 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 3.34 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 57.57 | 74.67 | Lower Risk |
Debt to Equity | -13.99 | -1.82 | Cheaper |
Debt to Assets | 0.81 | 0.26 | Expensive |
Market Cap | 444.02M | 3.73B | Emerging |